Loading
Latest filing published 11 Jul 2022 for Entasis Therapeutics Holdings Inc., €37k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
John Patrick Mueller (senior executive) discloses dealings in Entasis Therapeutics Holdings Inc. to SEC (Form 4). In total, 4 filings cover trades dated from 19 October 2021 to 7 July 2022.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 11 July 2022: a transaction of €37k, in Entasis Therapeutics Holdings Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations